Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fruchart

Showing results (441-450 of 562) with videos related to

Pageof 57
Sort By:
European Journal of Biochemistry|April 24, 1999
Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cellsG Martin, A Pilon, C Albert, et al.
Journal of Medical Genetics|November 5, 2002
CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemiaM N Slimane, S Lestavel, V Clavey, et al.
European Journal of Clinical Nutrition|March 11, 2003
Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitusD Quilliot, E Walters, P Böhme, et al.
Molecular Endocrinology (Baltimore, Md.)|March 17, 1999
Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response elementP Gervois, S Chopin-Delannoy, A Fadel, et al.
The Journal of Clinical Investigation|June 8, 2001
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IG Martin, H Duez, C Blanquart, et al.
The Journal of Biological Chemistry|February 5, 1993
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg)A von Eckardstein, G Castro, I Wybranska, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 studyJ M Bard, M A Charles, I Juhan-Vague, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1990
The increased plasma Lp(a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysisM C Alessi, H J Parra, P Joly, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 24, 1999
Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cellsV Clavey, C Copin, M C Mariotte, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Drug transfer across the blood-brain barrier: comparison of in vitro and in vivo modelsC Chesné, M P Dehouck, P Jolliet-Riant, et al.
Pageof 57

Showing results (441-450 of 562) with videos related to

Sort By:
Pageof 57
European Journal of Biochemistry|April 24, 1999
Comparison of expression and regulation of the high-density lipoprotein receptor SR-BI and the low-density lipoprotein receptor in human adrenocortical carcinoma NCI-H295 cellsG Martin, A Pilon, C Albert, et al.
Journal of Medical Genetics|November 5, 2002
CYS127S (FH-Kairouan) and D245N (FH-Tozeur) mutations in the LDL receptor gene in Tunisian families with familial hypercholesterolaemiaM N Slimane, S Lestavel, V Clavey, et al.
European Journal of Clinical Nutrition|March 11, 2003
Fatty acid abnormalities in chronic pancreatitis: effect of concomitant diabetes mellitusD Quilliot, E Walters, P Böhme, et al.
Molecular Endocrinology (Baltimore, Md.)|March 17, 1999
Fibrates increase human REV-ERBalpha expression in liver via a novel peroxisome proliferator-activated receptor response elementP Gervois, S Chopin-Delannoy, A Fadel, et al.
The Journal of Clinical Investigation|June 8, 2001
Statin-induced inhibition of the Rho-signaling pathway activates PPARalpha and induces HDL apoA-IG Martin, H Duez, C Blanquart, et al.
The Journal of Biological Chemistry|February 5, 1993
Interaction of reconstituted high density lipoprotein discs containing human apolipoprotein A-I (ApoA-I) variants with murine adipocytes and macrophages. Evidence for reduced cholesterol efflux promotion by apoA-I(Pro165-->Arg)A von Eckardstein, G Castro, I Wybranska, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2001
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 studyJ M Bard, M A Charles, I Juhan-Vague, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 30, 1990
The increased plasma Lp(a): B lipoprotein particle concentration in angina pectoris is not associated with hypofibrinolysisM C Alessi, H J Parra, P Joly, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 24, 1999
Cell culture conditions determine apolipoprotein CIII secretion and regulation by fibrates in human hepatoma HepG2 cellsV Clavey, C Copin, M C Mariotte, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
Drug transfer across the blood-brain barrier: comparison of in vitro and in vivo modelsC Chesné, M P Dehouck, P Jolliet-Riant, et al.
Pageof 57